Inhalers and nebulizers: Which to choose and why

Respiratory Medicine

Volumn 90, Issue 2, 1996, Pages 69-77

  Pedersen, S ^a  

^a KOLDING HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT; BUDESONIDE; FLUNISOLIDE; FLUTICASONE; TRIAMCINOLONE;

AEROSOL; HUMAN; INHALATION; INHALATIONAL DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; NEBULIZATION; NEBULIZER; PRIORITY JOURNAL; REVIEW;

EID: 0030000457     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(96)90201-2     Document Type: Review

References (65)

1. Matthys H. Inhalation delivery of asthma drugs. Lung 1990; 168: 645-652.
2. Bisgaard H. Aerosol treatment of young children. Eur Respir Rev 1994; 4(Suppl. 17): 17: 15-20.
3. Pedersen S. Inhaler use in children with asthma. Danish Med Bull 1987; 34: 234-249.
4. Prahl P, Jensen T. Decreased adrenocortical suppression utilizing the Nebuhaler for inhalation of steroid aerosols. Clin Allergy 1987; 17: 393-398.
5. Farrer M, Francis AJ, Pearce SJ. Morning serum cortisol concentrations after 2mg inhaled beclomethasone dipropionate in normal subjects: effect of a 750 ml spacing device. Thorax 1990; 46: 891-894.
6. Brown PH, Blundell G, Greening AP, Crompton GK. Do large volume spacer devices reduce the systemic effects of high dose corticosteroids? Thorax 1990; 45: 736-739.
7. Selroos O, Halme M. Effect of a volumatic spacer and mouth-rinsing on systemic absorption of inhaled corticosteroids from a metered dose inhaler and a dry powder inhaler. Thorax 1991; 46: 891-894.
8. Pedersen S, Hansen OR. Treatment of asthmatic children with budesonide from a Turbuhaler and a MDI with a Nebuhaler, 35th Nordic Congress of Pneumonology 1990, p. 35.
9. Dahlström K, Larsson P. Lung deposition and systemic availability of budesonide inhaled as nebulised suspension from different nebulisers. J Aer Med 1995; (in press).
10. 14C)disodium cromoglycate in man. J Pharm Pharmacol 1972; 24: 525-531.
11. Pedersen S, Frost L, Arnfred T. Errors in inhalation technique and efficacy of inhaler use in asthmatic children. Allergy 1986; 41: 118-124.
12. Pedersen S. Aerosol treatment of bronchoconstriction in children, with or without a tube spacer. N Engl J Med 1983; 308: 1328-1330.
13. Pedersen S, Østergaard PA. Nasal inhalation as a cause of inefficient pulmonary aerosol inhalation technique in children. Allergy 1983; 38: 191-194.
14. Pedersen S, Mortensen S. Use of different inhalation devices in children. Lung 1990; 168 (Suppl): 653-657.
15. Newman SP, Weisz AW, Talaee N, Clarke SW. Improvement of drug delivery with a breath actuated pressurized aerosol for patients with poor inhaler technique. Thorax 1991; 46: 712-716.
16. Ruggins NR, Milner AD, Swarbrick A. An assessment of a new breath actuated inhaler device in acutely wheezy children. Arch Dis Child 1993; 68: 477-480.
17. Pedersen S. Treatment of bronchoconstriction in children with a breath-actuated and a conventional metered dose inhaler. J All Clin Immunol 1992; 89: 154.
18. Newman SP, Pavia D, Morén F, Sheahan NF, Clarke SW. Deposition of pressurized aerosols in the human respiratory tracts. Thorax 1981; 36: 52-55.
19. Newman SP. Deposition and effects of inhalation aerosols (Thesis). Lund, Rahms Tryckeri, 1983.
20. Borgström L. Methodological Studies on Lung Deposition. Evaluation of Inhalation Devices and Absorption Mechanisms. Upsala: Acta Universitatis Upsaliensis, 1993, pp. 1-51.
21. Dolovich M, Ruffino RE, Roberts R, Newhouse MT. Optimal delivery of aerosols from metered dose inhalers. Chest 1981; 80 (Suppl. 65): 911-915.
22. Newman SP, Pavia D, Clarke SW. Improving the bronchial deposition of pressurized aerosols. Chest 1981; 80 (Suppl 65): 909-911.
23. Newman SP, Pavia D, Garland N, Clarke SW. Effects of various inhalation modes on the deposition of radioactive pressurized aerosols. Eur J Respir Dis 1982; 63 (Suppl 119): 57-65.
24. Fuglsang G, Pedersen S. Comparison of a new multidose powder inhaler with a pressurized aerosol in children with asthma. Pediatr Pulmonol 1989; 7: 112-115.
25. Pendergast J, Hopkins J, Timms B, Van Asperen PP. Comparative efficacy of terbutaline administered by Nebuhaler and by nebulizer in young children with acute asthma. Med J Aust 1989; 151: 406-408.
26. Noble V, Ruggins NR, Everad ML, Milner AD. Inhaled budesonide via a modified Nebuhaler for chronic wheezing in infants. Arch Dis Child 1992; 67: 285-288.
27. Connett GJ, Warde C, Wooler E, Lenney W. Use of budesonide in severe asthmatics aged 1-3 years. Arch Dis Child 1993; 69: 351-355.
28. Greenough A, Pool J, Gleeson JG, Price JF. Effect of budesonide on pulmonary hyperinflation in young asthmatic children. Thorax 1988; 43: 937-938.
29. Bisgaard H, Munck SL, Nielsen JP, Petersen W, Ohlsson SV. Inhaled budesonide for treatment of recurrent wheezing in early childhood. Lancet 1990; 336: 649-651.
30. Bisgaard H, Ohlsson S. PEP-spacer: an adaption for administration of MDI to infants. Allergy 1989; 44: 363-364.
31. Gleeson JG, Price JF. Controlled trial of budesonide given by the nebuhaler in preschool children with asthma. BMJ 1988; 297: 163-166.
32. Pool JB, Greenough A, Gleeson JG, Price JF. Inhaled bronchodilator treatment via the nebuhaler in young asthmatic patients. Arch Dis Child 1988; 63: 288-291.
33. Pedersen S. Optimal use of tube spacer aerosols in asthmatic children. Clin Allergy 1985; 15: 473-478.
34. Gleeson JG, Price JF. Nebuhaler technique. Br J Dis Chest 1988; 82: 172-174.
35. Newman SP, Millar AB, Lennard-Jones TR, Moren F, Clarke SW. Improvement of pressurised aerosol deposition with nebuhaler spacer device. Thorax 1984; 39: 935-941.
36. O'Callaghan C, Lynch J, Cant M, Robertson C. Improvement in sodium cromoglycate delivery from a spacer device by use of an antistatic lining, immediate inhalation, and avoiding multiple actuations of drug. Thorax 1993; 48: 603-606.
37. Clark AR, Rachelefsky G, Mason PL, Goldenhersh MJ, Hollingworth A. The use of reservoir devices for the simultaneous delivery of two metered-dose aerosols. J Allergy Clin Immunol 1990; 85: 75-79.
38. Newman SP, Woodman G, Moren F, Clarke SW. Bronchodilator therapy with nebuhaler: how important is the delay between firing the dose and inhaling? Br J Dis Chest 1988; 82: 262-267.
39. Newman SP, Morén F, Pavia D, Little F, Clarke SW. Deposition of pressurized suspension aerosols inhaled through extension devices. Am Rev Respir Dis 1981; 124: 317-320.
40. Morén F. Drug deposition of pressurized inhalation aerosols. I. Influence of actuator tube design. Int J Pharmacol 1978; 1: 205-212.
41. Everard ML, Clark AR, Milner AD. Drug delivery from holding chambers with attached facemask. Arch Dis Child 1992; 67: 580-585.
42. Lee H, Evans HE. Evaluation of inhalation aids of metered dose inhalers in asthmatic children. Chest 1987; 91: 366-369.
43. Richards R, Dickson CR, Renwick AG, Lewis RA, Holgate ST. Absorption and disposition kinetics of cromolyn sodium and the influence of inhalation technique. J Pharmacol Exp Ther 1987; 241: 1028-1032.
44. Auty RM, Brown K, Neale MG, Snashall PD. Respiratory tract deposition of sodium cromoglycate is highly dependent upon technique of inhalation using the Spinhaler. Br J Dis Chest 1987; 81: 371-380.
45. Fuller RW, Collier JG. The pharmacokinetic assessment of sodium cromoglycate. J Pharm Pharmacol 1983; 35: 289-292.
46. Vidgren M, Kärkkäinen A, Karjalainen P, Paronen P, Nuutinen J. Effect of powder inhaler design on drug deposition in the respiratory tract. Int J Pharm 1988; 42: 211-216.
47. Vidgren M, Paronen P, Vidgren P, Vainio P, Nuutinin J. In vivo evaluation of the new multiple dose powder inhaler and the Rotahaler using the gamma scintigraphy. Acta Pharm Nord 1990; 1: 3 10.
48. Roberts CM, Biddiscombe M, Fogarty P, Spiro SG. Lung deposition of dry powder salbutamol delivered by Rotahaler in subjects with chronic airflow obstruction. Eur Respir J 1990; 3 (Suppl. 10): 94.
49. Zainudin BMZ, Biddiscombe M, Tolfree SEJ, Short M, Spiro SG. Comparison of bronchodilator responses and deposition patterns of salbutamol inhaled from a pressurised metered dose inhaler, as a dry powder, and as nebulised solution. Thorax 1990; 45: 469-473.
50. Melchior EA. Lung deposition of salbutamol. Thorax 1993; 48: 506-511.
51. Biddiscombe M, Marriott RJ, Melchor R, Short MD, Spiro SG, Taylor AJ. The preparation and evaluation of pressurized metered dose and dry powder inhalers containing 99Tc labelled salbutamol. J Aer Med 1991; 4 (Suppl. 1): 9.
52. Newman SP, Morén F, Trofast E, Talaee N, Clarke SW. Deposition and clinical efficacy of terbutaline sulphate from Turbuhaler, a new multi-dose powder inhaler. Eur Respir J 1989; 2: 247-252.
53. Pedersen S. Treatment of acute bronchoconstriction in children with use of a tube spacer aerosol and a dry powder inhaler. Allergy 1985; 40: 300-304.
54. Pedersen S, Hansen OR, Fuglsang G. Influence of inspiratory flow rate upon the effect of a Turbuhaler. Arch Dis Child 1990; 65: 308-310.
55. Mercer TT. Production of therapeutic aerosols: principles and techniques. Chest 1981; 80 (Suppl.): 813-818.
56. Wood JA, Wilson RSE, Bray C. Changes in salbutamol concentration in the reservoir solution of a jet nebuliser. Br J Dis Chest 1986; 80: 164-169.
57. Clay MM, Pavia D, Newman SP, Lennard-Jones TR, Clarke SW. Assessment of jet nebulisers for lung aerosol therapy. Lancet 1983; ii: 592-594.
58. Matthys H, Köhler D. Pulmonary deposition of aerosols by different mechanical devices. Respiration 1985; 48: 269-276.
59. Sterk PJ, Plomp A, Van der Vate JF, Quanjer PH. Physical properties of aerosols produced by several jet and ultrasonic nebulizers. Bull Eur Physiopathol Respir 1984; 20: 65-72.
60. Lowenthal D, Kattan M. Facemasks versus mouthpieces for aerosol treatment of asthmatic children. Pediatr Pulmonol 1992; 14: 192-196.
61. Scalabrin DM, Naspitz CK. Efficacy and side effects of salbutamol in acute asthma in children: comparison of oral route and two different nebulizer systems. J Asthma 1993; 30: 51-59.
62. Ryan G, Dolovich MB, Obminski G et al. Standardisation of inhalation provocation tests: influence of nebulizer output, particle size and method of inhalation. J All Clin Immunol 1981; 67: 156-161.
63. Newman SP, Pellow PGD, Clay MM, Clarke WS. Evaluation of jet nebulizers for use with gentamycin solution. Thorax 1985; 40: 671-676.
64. Blackhall MI, O'Donnell SR. A dose-response study of inhaled terbutaline administered via nebuhaler or nebuliser to asthmatic children. Eur J Respir Dis 1987; 71: 96-101.
65. O'Callaghan C. Particle size of beclomethasone dipropionate produced by 2 nebulisers and spacers. Thorax 1990; 45: 109-111.